Drugmaker AstraZeneca will layoff 1,150 employees in its U.S. sales force, including some in leadership roles, the company said today. Less than 10 of positions affected are in Delaware, a company spokesman said.
The announcement from comes just two months after the Fairfax-based company, under pressure from generic drugmakers, announced 400 layoffs in its U.S. . Those layoffs are concentrated in Delaware and began to take effect this month.
“These changes are driven by the need to effectively compete in a challenging environment," said Tony Jewell, AstraZeneca spokesman. "We are building a leaner, U.S. organization that will enable us to continue delivering against our mission of patient health while remaining a strong, sustainable business in the future."
Layoff decisions will be finalized by February, Jewell said.